224 related articles for article (PubMed ID: 9388232)
1. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.
Ottilie S; Diaz JL; Horne W; Chang J; Wang Y; Wilson G; Chang S; Weeks S; Fritz LC; Oltersdorf T
J Biol Chem; 1997 Dec; 272(49):30866-72. PubMed ID: 9388232
[TBL] [Abstract][Full Text] [Related]
2. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity.
Zha J; Harada H; Osipov K; Jockel J; Waksman G; Korsmeyer SJ
J Biol Chem; 1997 Sep; 272(39):24101-4. PubMed ID: 9305851
[TBL] [Abstract][Full Text] [Related]
3. Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL.
Kelekar A; Chang BS; Harlan JE; Fesik SW; Thompson CB
Mol Cell Biol; 1997 Dec; 17(12):7040-6. PubMed ID: 9372935
[TBL] [Abstract][Full Text] [Related]
4. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
Huang DC; Adams JM; Cory S
EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional complementation of an inactive Bcl-2 mutant by Bax truncation.
Ottilie S; Diaz JL; Chang J; Wilson G; Tuffo KM; Weeks S; McConnell M; Wang Y; Oltersdorf T; Fritz LC
J Biol Chem; 1997 Jul; 272(27):16955-61. PubMed ID: 9202007
[TBL] [Abstract][Full Text] [Related]
6. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members.
Hsu SY; Lin P; Hsueh AJ
Mol Endocrinol; 1998 Sep; 12(9):1432-40. PubMed ID: 9731710
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the anti-apoptotic mechanism of Bcl-B.
Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
[TBL] [Abstract][Full Text] [Related]
8. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members.
Diaz JL; Oltersdorf T; Horne W; McConnell M; Wilson G; Weeks S; Garcia T; Fritz LC
J Biol Chem; 1997 Apr; 272(17):11350-5. PubMed ID: 9111042
[TBL] [Abstract][Full Text] [Related]
9. A splicing variant of the Bcl-2 member Bok with a truncated BH3 domain induces apoptosis but does not dimerize with antiapoptotic Bcl-2 proteins in vitro.
Hsu SY; Hsueh AJ
J Biol Chem; 1998 Nov; 273(46):30139-46. PubMed ID: 9804769
[TBL] [Abstract][Full Text] [Related]
10. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
Shangary S; Johnson DE
Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
[TBL] [Abstract][Full Text] [Related]
11. Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
Moreau C; Cartron PF; Hunt A; Meflah K; Green DR; Evan G; Vallette FM; Juin P
J Biol Chem; 2003 May; 278(21):19426-35. PubMed ID: 12642586
[TBL] [Abstract][Full Text] [Related]
12. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL.
Yamaguchi H; Wang HG
J Biol Chem; 2002 Nov; 277(44):41604-12. PubMed ID: 12198137
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions.
Moroy G; Martin E; Dejaegere A; Stote RH
J Biol Chem; 2009 Jun; 284(26):17499-511. PubMed ID: 19293158
[TBL] [Abstract][Full Text] [Related]
14. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL.
Simonian PL; Grillot DA; Merino R; Nuñez G
J Biol Chem; 1996 Sep; 271(37):22764-72. PubMed ID: 8798452
[TBL] [Abstract][Full Text] [Related]
15. Functional identification of the apoptosis effector BH3 domain in cellular protein BNIP1.
Yasuda M; Chinnadurai G
Oncogene; 2000 May; 19(19):2363-7. PubMed ID: 10822388
[TBL] [Abstract][Full Text] [Related]
16. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis.
Sattler M; Liang H; Nettesheim D; Meadows RP; Harlan JE; Eberstadt M; Yoon HS; Shuker SB; Chang BS; Minn AJ; Thompson CB; Fesik SW
Science; 1997 Feb; 275(5302):983-6. PubMed ID: 9020082
[TBL] [Abstract][Full Text] [Related]
17. Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing.
Wang K; Gross A; Waksman G; Korsmeyer SJ
Mol Cell Biol; 1998 Oct; 18(10):6083-9. PubMed ID: 9742125
[TBL] [Abstract][Full Text] [Related]
18. Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11.
Hsu SY; Kaipia A; Zhu L; Hsueh AJ
Mol Endocrinol; 1997 Nov; 11(12):1858-67. PubMed ID: 9369453
[TBL] [Abstract][Full Text] [Related]
19. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
Lama D; Sankararamakrishnan R
Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
[TBL] [Abstract][Full Text] [Related]
20. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak.
Zong WX; Lindsten T; Ross AJ; MacGregor GR; Thompson CB
Genes Dev; 2001 Jun; 15(12):1481-6. PubMed ID: 11410528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
